Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2019-01-09 Declaration of Voting R…
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
2019年第一次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is a formal announcement of the resolutions passed at the 2019 first extraordinary general meeting (临时股东大会) of Jiangsu Sihuan Bio-Pharmaceutical Co., Ltd. It details the meeting date, attendance, voting results, and legal opinions on the meeting's validity. The content focuses on the voting outcomes and procedural compliance rather than presenting a full report or financial statements. The document length is short (1615 characters) and it serves as an official disclosure of shareholder meeting resolutions and voting results. This matches the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2019-01-09 Chinese
关于公司收到中国证券监督管理委员会调查通知书的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company about receiving an investigation notice from the China Securities Regulatory Commission regarding suspected violations of information disclosure laws. It discusses potential risks related to stock suspension or delisting but does not contain financial statements, audit results, or detailed financial data. The document is relatively short (823 characters) and serves as a regulatory announcement about an ongoing investigation and potential regulatory actions. It does not fit into categories like Annual Report, Audit Report, or Earnings Release. It is best classified as a Regulatory Filing (RNS), which is the fallback category for such regulatory announcements and compliance-related disclosures.
2019-01-07 Chinese
关于诉讼的进展公告
Legal Proceedings Report Classification · 95% confidence The document is a public announcement from Jiangsu Sihuan Bio-Pharmaceutical Co., Ltd. regarding the progress of a litigation case. It details the background of the lawsuit, the court's decisions, and the current status of asset freezes and unfreezes related to the case. There are no financial statements, earnings data, or management discussions present. The document is focused solely on legal proceedings and updates about the lawsuit. Therefore, it fits the category of Legal Proceedings Report (LTR). The document length is short and it is not an announcement of a report publication, so it is not RPA or RNS. Hence, the classification is LTR with high confidence.
2019-01-07 Chinese
第八届监事会第八次会议决议公告
Audit Report / Information Classification · 90% confidence The document is a formal announcement from a company's supervisory board meeting regarding the change of the company's auditor for the 2018 annual audit. It includes details about the meeting, the decision to appoint a new audit firm, and the voting results. The document does not contain the audit report itself, nor does it include financial statements or detailed audit findings. Instead, it is an announcement of a board decision related to audit matters. This fits best under 'Audit Report / Information (AR)' as it pertains to audit-related information but is not a full annual report or standalone audit report. The document length is short and focused on audit firm change, not a full audit report or annual report. Therefore, the classification is AR with high confidence. FY 2018
2018-12-24 Chinese
关于公司变更会计师事务所的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the change of the company's auditor for the fiscal year 2018. It details the previous auditor, the newly appointed auditor, the approval process by the board and independent directors, and the upcoming shareholder meeting to approve the change. There are no financial statements or audit reports included, only the announcement of the auditor change. This fits the category of Audit Report / Information (AR) as it relates to audit matters but is not a full audit report or annual report itself. The document length is short and focused on the auditor change, not a full report or certification. Therefore, the best classification is AR with high confidence. FY 2018
2018-12-24 Chinese
第八届董事会第十一次会议决议公告
Board/Management Information Classification · 95% confidence The document is an announcement of resolutions passed at the 11th meeting of the 8th Board of Directors of Jiangsu Sihuan Bio. It includes decisions such as changing the auditing firm and convening an extraordinary general meeting. The document is short (740 characters) and does not contain financial statements or detailed financial data. It is a board/management information announcement about board decisions, not a full audit report or annual report. Therefore, it fits best under Board/Management Information (MANG).
2018-12-24 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.